Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.
2.

Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.

Nagy LM, Krystal JH, Charney DS, Merikangas KR, Woods SW.

J Clin Psychopharmacol. 1993 Feb;13(1):16-24.

PMID:
8098050
3.

Alprazolam in the treatment of panic attack patients with and without major depression.

Pyke RE, Kraus M.

J Clin Psychiatry. 1988 Feb;49(2):66-8.

PMID:
3338978
4.

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R Jr, DuPont RL Jr.

Arch Gen Psychiatry. 1988 May;45(5):437-43.

PMID:
3282480
5.

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.

Rickels K, Schweizer E, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):61-8.

PMID:
8422223
6.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

Pecknold JC, Swinson RP, Kuch K, Lewis CP.

Arch Gen Psychiatry. 1988 May;45(5):429-36.

PMID:
3282479
7.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP.

Arch Gen Psychiatry. 1988 May;45(5):413-22.

PMID:
3282478
8.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Schweizer E, Rickels K, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):51-60.

PMID:
8422222
9.

Discontinuation reactions to alprazolam in panic disorder.

Pecknold JC.

J Psychiatr Res. 1993;27 Suppl 1:155-70.

PMID:
8145176
10.
11.

Response to treatment in panic disorder with associated depression.

Maddock RJ, Blacker KH.

Psychopathology. 1991;24(1):1-6.

PMID:
2023978
12.
13.

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.

Marks IM, Swinson RP, Başoğlu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, et al.

Br J Psychiatry. 1993 Jun;162:776-87.

PMID:
8101126
14.

Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.

Başoğlu M, Marks IM, Kiliç C, Brewin CR, Swinson RP.

Br J Psychiatry. 1994 May;164(5):652-9.

PMID:
7921716
16.

The diagnosis and management of panic disorder.

Wood WG.

Psychiatr Med. 1990;8(3):197-209. Review.

PMID:
2202023
18.

Group cognitive-behavioral treatment of panic disorder.

Telch MJ, Lucas JA, Schmidt NB, Hanna HH, LaNae Jaimez T, Lucas RA.

Behav Res Ther. 1993 Mar;31(3):279-87.

PMID:
8476402
19.

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.

Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.

J Clin Psychopharmacol. 1990 Apr;10(2):112-8.

PMID:
2187912
20.

Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.

Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.

J Clin Psychopharmacol. 1989 Feb;9(1):22-7.

PMID:
2651490

Supplemental Content

Support Center